ArticleJournal of endocrinological investigation2026
Renal fat fraction quantified by MRI-Dixon predicts the renal function progression in patients with type 2 diabetes mellitus: a prospective cohort study.
Article in Journal of endocrinological investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- "One-stop-shop" medical imaging for osteoporosis and obese patients: a narrative review.Journal of endocrinological investigation · 2026Review
- Multimodal Magnetic Resonance Imaging in Diabetic Kidney Disease: From Pathophysiological Insights to Clinical Applications.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundLipid accumulation occurs in kidneys and leads to cellular damage. We aimed to investigate whether renal fat fraction (FF) is an independent predictor for the renal function progression in patients with type 2 diabetes mellitus (T2DM).
methodsRenal fat fraction (FF) was measured by MRI-Dixon imaging technique. 174 patients with T2DM were included in cross-sectional analysis, and 111 patients were enrolled in longitudinal analysis. After followed up for a median of 18.0 months, 21 of the 111 participants developed renal composite endpoint events. The outcomes were 30% decrease in eGFR from baseline, progression to chronic kidney disease (CKD) (eGFR < 60 ml/min/1.73m2) or end-stage renal disease (ESRD) (eGFR < 15 ml/min/1.73m2).
resultsIn cross-sectional analysis, multiple linear regression analysis showed that the renal FF was negatively correlated with baseline eGFR, with β coefficients (95% CI) of -16.03 (95% CI: -19.58 to -12.48) after confounders adjustment. In the prospective analysis, cox regression model revealed that each SD increment in baseline renal FF was associated with a higher incidence of renal composite endpoint events (HR = 3.78, 95% CI: 1.22–11.71). When renal FF values were categorized into tertiles, individuals in the highest tertile had an increased risk of renal composite endpoint events compared to those in the lowest tertile (HR = 18.27, 95% CI: 1.03-322.83). Furthermore, the combination of renal FF and uACR improved the predictive effect of renal composite endpoint events, with AUC of 0.78 (95% CI: 0.66–0.89).
conclusionRenal FF was closely associated with the renal function and may serve as a predictor of the renal function progression in patients with T2DM.
Indexed as
Identifiers
41432864What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.